Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 3 |
2021 | 1 |
2022 | 1 |
2023 | 1 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Lipid Metabolic Alterations in KRAS Mutant Tumors: Unmasking New Vulnerabilities for Cancer Therapy.
Int J Mol Sci. 2023 Jan 16;24(2):1793. doi: 10.3390/ijms24021793.
Int J Mol Sci. 2023.
PMID: 36675307
Free PMC article.
Review.
Restriction of extracellular lipids renders pancreatic cancer dependent on autophagy.
Saliakoura M, Sebastiano MR, Nikdima I, Pozzato C, Konstantinidou G.
Saliakoura M, et al.
J Exp Clin Cancer Res. 2022 Jan 8;41(1):16. doi: 10.1186/s13046-021-02231-y.
J Exp Clin Cancer Res. 2022.
PMID: 34998392
Free PMC article.
Item in Clipboard
ACSL3-PAI-1 signaling axis mediates tumor-stroma cross-talk promoting pancreatic cancer progression.
Rossi Sebastiano M, Pozzato C, Saliakoura M, Yang Z, Peng RW, Galiè M, Oberson K, Simon HU, Karamitopoulou E, Konstantinidou G.
Rossi Sebastiano M, et al. Among authors: saliakoura m.
Sci Adv. 2020 Oct 30;6(44):eabb9200. doi: 10.1126/sciadv.abb9200. Print 2020 Oct.
Sci Adv. 2020.
PMID: 33127675
Free PMC article.
Item in Clipboard
The ACSL3-LPIAT1 signaling drives prostaglandin synthesis in non-small cell lung cancer.
Saliakoura M, Reynoso-Moreno I, Pozzato C, Rossi Sebastiano M, Galié M, Gertsch J, Konstantinidou G.
Saliakoura M, et al.
Oncogene. 2020 Apr;39(14):2948-2960. doi: 10.1038/s41388-020-1196-5. Epub 2020 Feb 7.
Oncogene. 2020.
PMID: 32034305
Free PMC article.
Item in Clipboard
PLCγ1 suppression promotes the adaptation of KRAS-mutant lung adenocarcinomas to hypoxia.
Saliakoura M, Rossi Sebastiano M, Pozzato C, Heidel FH, Schnöder TM, Savic Prince S, Bubendorf L, Pinton P, A Schmid R, Baumgartner J, Freigang S, Berezowska SA, Rimessi A, Konstantinidou G.
Saliakoura M, et al.
Nat Cell Biol. 2020 Nov;22(11):1382-1395. doi: 10.1038/s41556-020-00592-8. Epub 2020 Oct 19.
Nat Cell Biol. 2020.
PMID: 33077911
Free PMC article.
Item in Clipboard
Synergistic effects of FGFR1 and PLK1 inhibitors target a metabolic liability in KRAS-mutant cancer.
Yang Z, Liang SQ, Saliakoura M, Yang H, Vassella E, Konstantinidou G, Tschan M, Hegedüs B, Zhao L, Gao Y, Xu D, Deng H, Marti TM, Kocher GJ, Wang W, Schmid RA, Peng RW.
Yang Z, et al. Among authors: saliakoura m.
EMBO Mol Med. 2021 Sep 7;13(9):e13193. doi: 10.15252/emmm.202013193. Epub 2021 Aug 8.
EMBO Mol Med. 2021.
PMID: 34369083
Free PMC article.
Item in Clipboard
Cite
Cite